T. Rowe Price Associates
DARE icon

T. Rowe Price Associates’s Dare Bioscience DARE Stock Holding History

T. Rowe Price Associates’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19K Hold
10,222
– – ﹤0.01% 3123
2025
Q4 		$20K Hold
10,222
– – ﹤0.01% 3079
2025
Q3 		$22K Hold
10,222
– – ﹤0.01% 3038
2025
Q2 		$25K Sell
10,222
-269
-3% -$785 ﹤0.01% 3043
2025
Q1 		$31K Hold
10,491
– – ﹤0.01% 2978
2024
Q4 		$33K Hold
10,491
– – ﹤0.01% 2969
2024
Q3 		$34K Buy
+10,491
New +$35.9K ﹤0.01% 2965
2024
Q2 		– Sell
-10,492
Closed -$62K – 2946
2024
Q1 		$62K Hold
10,492
– – ﹤0.01% 2846
2023
Q4 		$39K Hold
10,492
– – ﹤0.01% 2837
2023
Q3 		$59K Hold
10,492
– – ﹤0.01% 2754
2023
Q2 		$115K Hold
10,492
– – ﹤0.01% 2669
2023
Q1 		$131K Hold
10,492
– – ﹤0.01% 2634
2022
Q4 		$104K Hold
10,492
– – ﹤0.01% 2711
2022
Q3 		$126K Buy
10,492
+5,609
+115% +$77K ﹤0.01% 2669
2022
Q2 		$72K Hold
4,883
– – ﹤0.01% 2820
2022
Q1 		$87K Buy
+4,883
New +$92.3K ﹤0.01% 2870

Other funds holding DARE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates's DARE Position: Q1 2026 in Review

T. Rowe Price Associates held its Dare Bioscience (DARE) position steady in Q1 2026 at 10,222 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #3123.

T. Rowe Price Associates first reported a position in DARE in Q1 2022 and has held it in 16 quarters since. The position peaked at $131K in Q1 2023. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • T. Rowe Price Associates held 10,222 shares of Dare Bioscience worth $19K as of Q1 2026.
  • T. Rowe Price Associates left its Dare Bioscience share count unchanged in Q1 2026.
  • Dare Bioscience made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #3123 holding.
  • T. Rowe Price Associates first reported a position in Dare Bioscience in Q1 2022 and has held it in 16 quarters since.
  • T. Rowe Price Associates's Dare Bioscience position peaked at $131K in Q1 2023.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.